Clinical Trials Data Epilepsy Terpenes 
Veriheal
APRIL 11, 2022
We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. This means that U.S.
The Joint Blog
JANUARY 23, 2020
. “Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. One isolated study indicates some potential efficacy for an oral cannabinoid /terpene combination in ADHD.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
JUNE 15, 2021
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). It’s everywhere. An anti-seizure wonder drug.
CannaTech
SEPTEMBER 16, 2018
But this gap restricts patient access to a medicine that can offer relief to a long list of conditions including chronic pain, seizures attributed to epilepsy, as well as mood disorders such as anxiety and depression. This knowledge gap isn’t surprising, as cannabis as a medicine is non-traditional in its very nature.
Greencamp
AUGUST 16, 2018
The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.
Cannabis Law Report
NOVEMBER 24, 2021
At the same time, the outlook on cannabis research data is largely positive. Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Data collection. Palliative care indications.
Green Relief
MAY 13, 2018
As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. It is the most commonly identified cause of epilepsy among adults. Preliminary data suggests that a synergistic combination of CBD and hypothermia may produce the best results.
Expert insights. Personalized for you.
104 
Let's personalize your content